🌟Toniic and NLC have been partnering for the last few years to bring more science to life through meaningful investments. Read more about why Toniic members have invested in NLC and the NLC Health Impact Fund in their latest article here: https://lnkd.in/ga_jjXHe @AvalonHillManagement Edmond H. #impactinvesting #healthcare #healthtech #innovation #venturecapital
NLC Health Ventures
Durfkapitaal en privévermogen
We find, build and scale transformative health innovations.
Over ons
NLC Health Ventures - is dedicated to advancing health, making it accessible for everyone. By using entrepreneurship at scale, our unique NLC approach allows us to find inventions, and create and support ventures that have the potential to reach the patient. Led by winning teams, together with a dedicated network and driven by data and learnings.
- Website
-
http://www.nlc.health
Externe link voor NLC Health Ventures
- Branche
- Durfkapitaal en privévermogen
- Bedrijfsgrootte
- 51 - 200 medewerkers
- Hoofdkantoor
- Amsterdam
- Type
- Particuliere onderneming
- Opgericht
- 2014
- Specialismen
- investment, life science, strategy, business development, medical technology, entrepreneurship, commercialization, ehealth, incubation, improving healthcare, finance, medical devices, innovation, health tech, venture building en invention
Locaties
-
Primair
Amsterdam Health and Technology Center
Paasheuvelweg 25
Amsterdam, 1105 BP, NL
Medewerkers van NLC Health Ventures
Updates
-
🌍Are you ready to play a pivotal role in shaping the future of biotechnology? We are on a lookout for a Venture Partner with a deep understanding of the #biotech / #pharma investment industry, particularly in early-stage drug development. In this role you will take ownership of our biotech portfolio, and build long-term partnerships for NLC and our ventures to develop #NovelDrugs that will reach the patient. 🚀Your responsibilities will include guiding and supporting our ventures, managing the existing biotech portfolio, and collaborating with the team to further develop the cluster. You will also represent NLC as the founding shareholder, establish strategic partnerships with institutions and corporates, and work to identify and commercialize emerging technologies in #biopharma. If you're ready to be a catalyst for advanced biotech solutions, and be part of a team driven by togetherness, openness, decisiveness, and optimism, we want to hear from you! Apply here: https://lnkd.in/dWd6YpQM #CareerOpportunity #Hiring #VenturePartner #BioTech #Pharma #Entrepreneurship #PortfolioManagement #Commercialisation
-
NLC Venture Mitracept joins the Fogarty Innovation’s company accelerator program 🎉 Mitracept is led by CEO and co-founder Tejas Mazmudar, an expert with extensive experience in #medtech, and Dr. Mayra Guerrero, an interventional cardiologist at the Mayo Clinic and a key opinion leader in the transcatheter mitral valve replacement (TMVR) space. Current mortality rates of mitral regurgitation are as high as 50%, if not treated within five years of onset. As a solution, Mitracept provides a unique approach to mitigate the risks associated with #TMVR, expanding treatment options for patients who are currently ineligible due to life-threatening complications. Best of luck to Mitracept, with exciting times ahead for the future of cardiac care! 🫀 For more information, read the article here: https://lnkd.in/g-dN3UrT #Innovation #Healthcare #Acceleration #CardiacCare
Engineering Health: New Fogarty Company Mitracept Creates Options for Patients with Mitral Valve Disease - Fogarty Innovation
https://www.fogartyinnovation.org
-
💚 Kickstart Your Career with Our Impact & ESG Internship! 🌍 Are you passionate about social impact, sustainability, and corporate responsibility? Do you want to gain hands-on experience in ESG, impact measurement, and venture building? Work closely with Johanneke Maenhout and Jikke de Jong to build NLC’s 2024 Impact Report and make a real difference in healthcare innovation. 🔍 What You'll Do: - Analyze data: Gather and interpret data on our ventures' impact - Craft stories: Showcasing our real-world impact - Create content: Contribute to the 2024 Impact Report 📅 Details: - Duration: 5 months, starting in October - Compensation: 600 euros/month (full-time) - Location: Based in the Netherlands Preferred backgrounds: Master’s students in Global Health, Healthcare Management, Health Economics, Data Analytics, Environmental Science, Sustainable Development, or similar fields. Other disciplines are also welcome! 🔗 Apply Here: https://lnkd.in/dZaGR97J #Internship #Impact #ESG #HealthTech #Sustainability #CareerOpportunity
-
🌟 Now is the Time for Philanthropic Funds to Invest in Impact Funds 🌟 A recent change in the implementation of ANBI regulations makes it easier for philanthropic funds to invest in impact funds. Foundations can now use not only their capital to invest, but also the gains from their investments, as long as they align with the foundation’s goals. This opens up new, scalable ways to contribute to social objectives. Previously, such investments required individual agreements with tax authorities, discouraging smaller funds. Thanks to FIN - Branchevereniging van fondsen en foundations and its members, this barrier has been removed. "The simplification of the implementation regulation has provided an extra tool for funds to make an impact with their income. This creates a level playing field for all foundations," says Siep Wijsenbeek, director at FIN - Branchevereniging van fondsen en foundations. 🎉 Recently, the Stichting mr. Roelsefonds invested €1 million in the NLC Health Impact Fund, focusing on early-stage health innovations. This investment showcases how the new rules can be practically applied and serves as a model for other foundations. "Investing in an impact fund like the NLC Health Impact Fund allows us to achieve financial returns while improving quality of care," says Tessa van der Valk, director of the Stichting mr. Roelsefonds. The change in implementation regulations is a significant step towards facilitating impact investments by philanthropic funds. By simplifying the investment process, it paves the way for a sustainable and impactful future. As more funds follow this example, the potential for positive change grows. For more information on this change in the implementation regulation, read the full article here: https://lnkd.in/diYGyFHZ Nina Rijnders Financial Investigator #ImpactInvesting #Healthcare #HealthTech #Innovation #ImpactFunds
Nina Rijnders: Impactbeleggen voor filantropische fondsen
financialinvestigator.nl
-
Great news from SERDA therapeutics! 🎉 NLC’s Venture SERDA therapeutics successfully completes its first Phase 1 Human Clinical Study of their SN514 hydrogel. SERDA therapeutics is a biopharmaceutical company focused on developing improved treatments for burns and chronic wounds with an innovative enzymatic wound debriding agent. SERDA’s hydrogel offers fast debridement, ease of use, high stability, and low-moderate irritation. The recent Phase 1 study of healthy adult volunteers indicated that additional protection may not be needed on the surroundings of healthy skin. Detailed results will be presented in December 2024, at the Innovations in Wound Healing Conference by Well-Assembled Meetings & Associations. Gabor Heltovics, CEO of SERDA, expressed confidence in SN514's ability to set a new standard in wound care, while Bert Slade, CMO, highlighted the upcoming dose-ranging tolerability study in order to determine the safety of SN514 for deep partial thickness burn wounds. Curious to know more about the clinical trials? Find the press release here in the link attached: https://lnkd.in/dDtggSAd #WoundCare #ClinicalTrials #healthtech #biotech #innovation #startup #investment
SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514.
https://serda-therapeutics.com
-
Bilihome, our portfolio company, is featured in NeoPrediX AG’s latest paper, NeoPrediX 2024 Innovation Showcase: Groundbreaking Neonatology Startups to Watch! Bilihome is transforming the way newborn jaundice is treated with their innovative wearable phototherapy solution. From breastfeeding to skin-to-skin contact and even while being carried around, Bilihome ensures that the precious moments between parents and their little ones remain uninterrupted while delivering effective jaundice treatment. Congratulations to the entire Bilihome team! 🎉 #Neonatology #HealthcareInnovation #Medicalinnovation Margret Huenerbein Rick Wielens BILIHOME B.V.
-
We are hiring! NLC is looking for an Entrepreneur in Residence to drive our ventures forward. Are you passionate about bringing groundbreaking science to life? 🌟 Do you thrive in incubating and growing new ventures? 🚀 Join us at NLC, where you can leverage your strategic talent and biotech expertise to shape the future of therapeutic innovations! 💡 We are seeking an Entrepreneur in Residence with a visionary mindset and deep expertise in biotech/pharma. In this role, you will evaluate and build new therapeutic ventures, define strategies, and drive them from pre-clinical stages to maturation. Your responsibilities will include developing comprehensive business plans, managing stakeholder relationships, and leading fundraising efforts. This is a unique opportunity to drive emerging biotech ventures, forge strategic partnerships, and contribute to NLC’s thriving innovation ecosystem. 🌍 Join us and be a catalyst for breakthrough biotech solutions! 🌐 Apply here: https://lnkd.in/dnjGQ9h3 #JobOpening #JoinUs #Hiring #CareerOpportunity #NLCHealthVentures #HealthTech #Hiring #Entrepreneur #BioTech #Pharma #Therapeutics
-
A recent change in the implementation of ANBI regulations, made possible by members of FIN Branchevereniging van fondsen en foundations, has opened exciting opportunities for wealth funds to focus more on impact investments. These regulations now make it easier for philanthropic wealth funds to invest in impactful ventures. Stichting mr. Roelsefonds, an early adopter of impact investing for foundations, recently invested €1 million in The NLC Health Impact Fund. They recognize the power of impact investing as a tool to drive meaningful social and environmental change: “We have discovered that investments which are both sustainable and impactful yield positive results for society and provide strong financial returns. By collaborating with specialized funds like the NLC Health Impact Fund, we can significantly improve healthcare while also achieving our financial objectives," says Tessa van der Valk, Chairwoman of mr. Roelsefonds. We are super excited about this partnership and the support from mr. Roelsefonds helps us bring even more technology to the patients who need it the most. Curious to read more about this partnership? Read the article in the De Dikke Blauw co-written by mr. Roelsefonds, FIN - Branchevereniging van fondsen en foundations, Siep Wijsenbeek and NLC. You find a link to the article in the comments. #healthcare #innovation #impact #investment #vermogen #stichting #investeren #vermogensfondsen #fonds
-
🌟 Our portfolio company StarTric has successfully secured seed funding to transform the treatment of #TricuspidRegurgitation! 💡❤️ StarTric's innovative technology combines the safety of a minimally invasive percutaneous procedure with the proven Clover edge-to-edge surgical technique developed by Prof. Ottavio Alfieri and Prof. Michele De Bonis. This breakthrough approach aims to provide unprecedented efficacy, personalized treatment, and ease of use for patients suffering from tricuspid valve regurgitation. The funding round saw participation from experienced early-stage investors, including the NLC Health Impact Fund, Growth Engine, and Business Angels. Congratulations to Eugenio Passanante, DANIELE ZANOTTI and the rest of the StarTric team on this significant milestone! 🚀 Read more about StarTric and their technology in Silicon Canals - European Technology News’ article via the link in the comments below. Alessandro Radaelli #NLC #StarTric #HealthTech #Innovation #Cardiology #MedicalDevices #ImpactInvesting
Vergelijkbare pagina’s
Door vacatures bladeren
Financiering
Laatste ronde
BedrijfsrondeUS$ 6.544.353,00
Investeerders
Coöperatie VGZ